vs
Side-by-side financial comparison of Sila Realty Trust, Inc. (SILA) and STEM, INC. (STEM). Click either name above to swap in a different company.
Sila Realty Trust, Inc. is the larger business by last-quarter revenue ($50.1M vs $47.1M, roughly 1.1× STEM, INC.). Sila Realty Trust, Inc. runs the higher net margin — 10.0% vs -33.9%, a 43.9% gap on every dollar of revenue. On growth, Sila Realty Trust, Inc. posted the faster year-over-year revenue change (7.6% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -0.6%).
Sila Realty Trust, Inc. is a U.S.-based real estate investment trust that owns, operates, and acquires high-quality income-generating commercial properties. Its core portfolio covers industrial logistics facilities, office assets and mixed-use properties, serving tenants across logistics, corporate and retail segments to deliver stable long-term returns.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
SILA vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.1M | $47.1M |
| Net Profit | $5.0M | $-16.0M |
| Gross Margin | 88.9% | 48.9% |
| Operating Margin | — | -17.7% |
| Net Margin | 10.0% | -33.9% |
| Revenue YoY | 7.6% | -15.6% |
| Net Profit YoY | -54.9% | 68.8% |
| EPS (diluted) | $0.10 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.1M | $47.1M | ||
| Q3 25 | $49.8M | $38.2M | ||
| Q2 25 | $48.7M | $38.4M | ||
| Q1 25 | $48.3M | $32.5M | ||
| Q4 24 | $46.5M | $55.8M | ||
| Q3 24 | $46.1M | $29.3M | ||
| Q2 24 | $43.6M | $34.0M | ||
| Q1 24 | $50.6M | $25.5M |
| Q4 25 | $5.0M | $-16.0M | ||
| Q3 25 | $11.6M | $-23.8M | ||
| Q2 25 | $8.6M | $202.5M | ||
| Q1 25 | $7.9M | $-25.0M | ||
| Q4 24 | $11.1M | $-51.1M | ||
| Q3 24 | $11.9M | $-148.3M | ||
| Q2 24 | $4.6M | $-582.3M | ||
| Q1 24 | $15.0M | $-72.3M |
| Q4 25 | 88.9% | 48.9% | ||
| Q3 25 | 88.1% | 35.5% | ||
| Q2 25 | 87.7% | 33.4% | ||
| Q1 25 | 86.9% | 32.4% | ||
| Q4 24 | 87.3% | -4.4% | ||
| Q3 24 | 87.4% | 21.2% | ||
| Q2 24 | 86.6% | 27.6% | ||
| Q1 24 | 89.0% | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | 10.0% | -33.9% | ||
| Q3 25 | 23.3% | -62.2% | ||
| Q2 25 | 17.6% | 527.8% | ||
| Q1 25 | 16.4% | -76.9% | ||
| Q4 24 | 23.9% | -91.6% | ||
| Q3 24 | 25.9% | -506.3% | ||
| Q2 24 | 10.6% | -1712.6% | ||
| Q1 24 | 29.6% | -283.9% |
| Q4 25 | $0.10 | $-4.40 | ||
| Q3 25 | $0.21 | $-2.84 | ||
| Q2 25 | $0.15 | $-1.79 | ||
| Q1 25 | $0.14 | $-0.15 | ||
| Q4 24 | $0.20 | $-15.29 | ||
| Q3 24 | $0.21 | $-18.24 | ||
| Q2 24 | $0.08 | $-71.81 | ||
| Q1 24 | $0.26 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $32.3M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $-249.4M |
| Total Assets | $2.1B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $32.3M | $48.9M | ||
| Q3 25 | $27.7M | $43.1M | ||
| Q2 25 | $24.8M | $40.8M | ||
| Q1 25 | $30.5M | $58.6M | ||
| Q4 24 | $39.8M | $56.3M | ||
| Q3 24 | $28.6M | $75.4M | ||
| Q2 24 | $87.0M | $89.6M | ||
| Q1 24 | $90.2M | $112.8M |
| Q4 25 | $1.3B | $-249.4M | ||
| Q3 25 | $1.3B | $-235.7M | ||
| Q2 25 | $1.4B | $-214.1M | ||
| Q1 25 | $1.4B | $-417.5M | ||
| Q4 24 | $1.4B | $-398.4M | ||
| Q3 24 | $1.4B | $-344.1M | ||
| Q2 24 | $1.5B | $-203.2M | ||
| Q1 24 | $1.5B | $371.6M |
| Q4 25 | $2.1B | $308.9M | ||
| Q3 25 | $2.1B | $362.6M | ||
| Q2 25 | $2.0B | $379.2M | ||
| Q1 25 | $2.0B | $405.1M | ||
| Q4 24 | $2.0B | $437.4M | ||
| Q3 24 | $2.0B | $537.8M | ||
| Q2 24 | $2.1B | $691.5M | ||
| Q1 24 | $2.1B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $119.1M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 23.76× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.1M | $8.2M | ||
| Q3 25 | $30.0M | $11.4M | ||
| Q2 25 | $31.9M | $-21.3M | ||
| Q1 25 | $24.1M | $8.5M | ||
| Q4 24 | $132.8M | $-14.7M | ||
| Q3 24 | $29.1M | $-9.4M | ||
| Q2 24 | $31.6M | $-11.9M | ||
| Q1 24 | $36.6M | $-621.0K |
| Q4 25 | 23.76× | — | ||
| Q3 25 | 2.59× | — | ||
| Q2 25 | 3.71× | -0.11× | ||
| Q1 25 | 3.06× | — | ||
| Q4 24 | 11.95× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 6.84× | — | ||
| Q1 24 | 2.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
